Protocol · Musculoskeletal Health
Ehlers-Danlos Syndrome (EDS) Supportive Care Protocol
Vitamin C and Magnesium are the core of this stack, with 7 supporting supplements. Each row gives the amount the protocol lists and the grade our evidence database holds for that supplement in Ehlers-Danlos Syndrome (EDS) Supportive Care.
We are re-verifying the studies cited on protocol pages; only confirmed citations are shown.
The stack
9 supplements · none graded yet
| Grade | Supplement | Amount listed | Why it’s in the stack | Evidence on file |
|---|---|---|---|---|
| Primary stackThe core of this protocol | ||||
| Vitamin C | Amount listed: 1,000–2,000 mg daily in divided doses | Essential for collagen synthesis; theoretical benefit for connective tissue support in EDS | Not graded yet | |
| Magnesium | Amount listed: 300–400 mg daily | Supports muscle function; may help with muscle cramps and pain common in EDS | Not graded yet | |
| Supporting stackListed as additions to the core | ||||
| Collagen Peptides | Amount listed: 10–15 g daily | May support connective tissue; theoretical benefit in collagen disorders; limited EDS-specific evidence | Not graded yet | |
| Omega-3 Fatty Acids | Amount listed: 2–4 g EPA+DHA daily | Anti-inflammatory; may help with chronic pain common in EDS | Not graded yet | |
| Vitamin D | Amount listed: 2,000–4,000 IU daily | Supports bone health; important given EDS patients may have reduced activity levels | Not graded yet | |
| Glucosamine Sulfate | Amount listed: 1,500 mg daily | Supports cartilage; may help with joint symptoms | Not graded yet | |
| B-Complex Vitamins | Amount listed: B-complex daily | Supports energy and nervous system; fatigue common in EDS | Not graded yet | |
| Coenzyme Q10 | Amount listed: 100–200 mg daily | May help with fatigue and muscle symptoms | Not graded yet | |
| MSM (Methylsulfonylmethane) | Amount listed: 1,000–3,000 mg daily | Sulfur compound that may support connective tissue and reduce inflammation | Not graded yet | |
How this protocol works
In plain language
Ehlers-Danlos Syndrome (EDS) is a group of inherited connective tissue disorders caused by defects in collagen and other connective tissue proteins. The 2017 classification identifies 13 types, with hypermobile EDS (hEDS) being the most common.
TYPES OF EDS:
- Hypermobile EDS (hEDS): Most common; joint hypermobility, pain, fatigue
- Classical EDS (cEDS): Very stretchy, fragile skin; easy bruising
- Vascular EDS (vEDS): Serious - risk of arterial and organ rupture
- Kyphoscoliotic, Arthrochalasia, Dermatosparaxis, and others: Rare types
SYMPTOMS vary by type but commonly include:
- Joint hypermobility and instability
- Chronic pain (often widespread)
- Fatigue
- Easy bruising
- Stretchy or fragile skin
- Poor wound healing
- Digestive problems
- Dysautonomia (POTS)
CRITICAL: EDS requires specialized medical care. Vascular EDS can be life-threatening. This protocol is SUPPORTIVE ONLY.
MANAGEMENT INCLUDES:
- Physical therapy: Core strengthening, joint protection, proprioception
- Pain management: Multimodal approach
- Joint protection: Bracing, taping, activity modification
- Cardiovascular evaluation: Especially for vascular EDS
- POTS management: If dysautonomia present
- GI evaluation: For motility issues
Vitamin C* is essential for collagen synthesis and may theoretically support connective tissue.
Magnesium* may help with muscle cramps and pain.
Collagen peptides* are taken by many EDS patients though specific evidence is lacking.
Omega-3s* may help with chronic pain and inflammation.
Expected timeline: EDS is a lifelong condition. Supplements may provide gradual support. Physical therapy and lifestyle modifications are key to management.